A Study to Test DSP107 in Combination With Atezolizumab in Comparison With Fruquintinib as a New Treatment for Colorectal Cancer.
Clinical trial NCT07235293 · RECRUITING
Trial details
- NCT number
- NCT07235293
- Sponsor
- Kahr Bio Australia Pty Ltd
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-01-16
- Primary completion
- 2026-09-30
- Enrollment
- 90
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.